Pharmacology and therapeutic use of calcitonin

Drugs
J C Stevenson, I M Evans

Abstract

Calcitonin is a peptide hormone secreted by the C-cells of the thyroid gland. A major physiological function of the hormone appears to be the protection of the skeleton against resorption in humans. It thus opposes the resorptive actions of parathyroid hormone and 1,25 dihydroxyvitamin D. This action is utilised pharmacologically in order to treat diseases where increased bone resorption is a major component. The efficacy of calcitonin in the treatment of Paget's disease of bone is well established, especially as it is currently the most effective agent in the treatment of the osteolytic form of the disease. In other bone diseases where resorption of bone is a component it is likely to be worthy of a trial of therapy. There are also sound theoretical reasons why calcitonin may be of benefit in the treatment of certain osteoporoses, especially in combination with other agents. Most recent studies would seem to support his view. A disadvantage of calcitonin therapy is that the hormone has to be administered parenterally, although future developments may obviate this. It is, however, a form of retreatment which is free of any long term serious side effects, and calcitonin now has a definite place in the management of specific bone...Continue Reading

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·C WüsterR Ziegler
Dec 1, 1983·Molecular and Cellular Endocrinology·D M SalmonJ M Zanelli
Feb 1, 2003·European Journal of Pharmacology·Kenta NishikiAkio Fujimura
Apr 23, 1983·Lancet
Aug 30, 2000·Advanced Drug Delivery Reviews·Y H Lee, P J Sinko
Jan 11, 2000·Domestic Animal Endocrinology·H A HazewinkelJ A Mol
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·K MorimotoY Ikada
Aug 30, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Y Hee LeeP J Sinko
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·S T DogruF Oner
May 21, 1983·British Medical Journal·C R Paterson, J Feely
Jul 6, 1985·British Medical Journal·J C Stevenson
Jan 1, 1988·Chronobiology International·B TarquiniM Cecchettin
Oct 1, 1984·Journal of Pharmaceutical Sciences·K MorimotoK Morisaka
Mar 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A J FelsenfeldM Rodriguez
Jul 13, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf LamprechtYoshiaki Kawashima
Aug 30, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y LiY L Hao
Mar 8, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Christian BijaniErick J Dufourc
Jun 30, 2000·The Journal of Pharmacy and Pharmacology·K MorimotoY Ikada
Jul 6, 1985·British Medical Journal
Feb 1, 1988·British Journal of Haematology·D G Oscier, J C Stevenson
Sep 1, 1987·Annals of Tropical Paediatrics·M IbrahimC G Iwegbu
Nov 1, 1982·Journal of Endocrinological Investigation·H J Wolfe
Dec 8, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Yuanjin ChenYunxia Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved